List of Tables

Table 1. Polyvalent Streptococcus Pneumococcal Vaccines Consumption Value & CAGR: China VS Global, 2020-2031, US$ Million

Table 2. Polyvalent Streptococcus Pneumococcal Vaccines Market Restraints

Table 3. Polyvalent Streptococcus Pneumococcal Vaccines Market Trends

Table 4. Polyvalent Streptococcus Pneumococcal Vaccines Industry Policy

Table 5. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 6. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Share by Company, 2020-2025, Ranked by Data of 2024

Table 7. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Quantity by Company, (2020-2025) & (K Units), Ranked Based on Sales in 2024

Table 8. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Quantity by Company, 2020-2025, Ranked by Data of 2024

Table 9. Global Polyvalent Streptococcus Pneumococcal Vaccines Average Selling Price (ASP) by Company, (2020-2025) & (US$/Unit)

Table 10. Global Polyvalent Streptococcus Pneumococcal Vaccines Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Polyvalent Streptococcus Pneumococcal Vaccines Mergers & Acquisitions, Expansion Plans

Table 12. Global Polyvalent Streptococcus Pneumococcal Vaccines Manufacturers Product Type

Table 13. Head Office and Polyvalent Streptococcus Pneumococcal Vaccines Production Site of Key Manufacturer

Table 14. Polyvalent Streptococcus Pneumococcal Vaccines Capacity of Major Manufacturers and Future Plan

Table 15. China Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 16. China Polyvalent Streptococcus Pneumococcal Vaccines Revenue Share by Company, 2020-2025, Ranked by Data of 2024

Table 17. China Polyvalent Streptococcus Pneumococcal Vaccines Sales Quantity by Company, (2020-2025) & (K Units), Ranked Based on Sales in 2024

Table 18. China Polyvalent Streptococcus Pneumococcal Vaccines Sales Quantity by Company, 2020-2025, Ranked by Data of 2024

Table 19. Global Polyvalent Streptococcus Pneumococcal Vaccines Production & Forecast by Region, 2020 VS 2024 VS 2031, (K Units)

Table 20. Global Polyvalent Streptococcus Pneumococcal Vaccines Production by Region, 2020-2025, (K Units)

Table 21. Global Polyvalent Streptococcus Pneumococcal Vaccines Production Forecast by Region, 2026-2031, (K Units)

Table 22. Global Key Players of Polyvalent Streptococcus Pneumococcal Vaccines Upstream (Raw Materials)

Table 23. Global Polyvalent Streptococcus Pneumococcal Vaccines Typical Customers

Table 24. Polyvalent Streptococcus Pneumococcal Vaccines Typical Distributors

Table 25. by Type, Global Polyvalent Streptococcus Pneumococcal Vaccines Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 26. by Application, Global Polyvalent Streptococcus Pneumococcal Vaccines Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 27. By Region, Global Polyvalent Streptococcus Pneumococcal Vaccines Consumption Value, 2020 VS 2024 VS 2031, US$ Million

Table 28. By Region, Global Polyvalent Streptococcus Pneumococcal Vaccines Consumption Value, 2020-2031, US$ Million

Table 29. By Region, Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Quantity, 2020-2031, (K Units)

Table 30. By Country, Global Polyvalent Streptococcus Pneumococcal Vaccines Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 31. By Country, Global Polyvalent Streptococcus Pneumococcal Vaccines Consumption Value, 2020-2031, US$ Million

Table 32. By Country, Global Polyvalent Streptococcus Pneumococcal Vaccines Consumption Value Market Share, 2020-2031

Table 33. By Country, Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Quantity, 2020-2031, (K Units)

Table 34. By Country, Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Quantity Market Share, 2020-2031

Table 35. GlaxoSmithKline Company Information, Head Office, Market Area, and Industry Position

Table 36. GlaxoSmithKline Polyvalent Streptococcus Pneumococcal Vaccines Models, Specifications, and Application

Table 37. GlaxoSmithKline Polyvalent Streptococcus Pneumococcal Vaccines Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 38. GlaxoSmithKline Company Profile and Main Business

Table 39. GlaxoSmithKline Recent Developments

Table 40. Merck Company Information, Head Office, Market Area, and Industry Position

Table 41. Merck Polyvalent Streptococcus Pneumococcal Vaccines Models, Specifications, and Application

Table 42. Merck Polyvalent Streptococcus Pneumococcal Vaccines Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 43. Merck Company Profile and Main Business

Table 44. Merck Recent Developments

Table 45. Panacea Biotec Company Information, Head Office, Market Area, and Industry Position

Table 46. Panacea Biotec Polyvalent Streptococcus Pneumococcal Vaccines Models, Specifications, and Application

Table 47. Panacea Biotec Polyvalent Streptococcus Pneumococcal Vaccines Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 48. Panacea Biotec Company Profile and Main Business

Table 49. Panacea Biotec Recent Developments

Table 50. Pfizer Company Information, Head Office, Market Area, and Industry Position

Table 51. Pfizer Polyvalent Streptococcus Pneumococcal Vaccines Models, Specifications, and Application

Table 52. Pfizer Polyvalent Streptococcus Pneumococcal Vaccines Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 53. Pfizer Company Profile and Main Business

Table 54. Pfizer Recent Developments

Table 55. Pnuvax Incorporated Company Information, Head Office, Market Area, and Industry Position

Table 56. Pnuvax Incorporated Polyvalent Streptococcus Pneumococcal Vaccines Models, Specifications, and Application

Table 57. Pnuvax Incorporated Polyvalent Streptococcus Pneumococcal Vaccines Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 58. Pnuvax Incorporated Company Profile and Main Business

Table 59. Pnuvax Incorporated Recent Developments

Table 60. Serum Institute Company Information, Head Office, Market Area, and Industry Position

Table 61. Serum Institute Polyvalent Streptococcus Pneumococcal Vaccines Models, Specifications, and Application

Table 62. Serum Institute Polyvalent Streptococcus Pneumococcal Vaccines Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 63. Serum Institute Company Profile and Main Business

Table 64. Serum Institute Recent Developments

Table 65. Shinogi Company Information, Head Office, Market Area, and Industry Position

Table 66. Shinogi Polyvalent Streptococcus Pneumococcal Vaccines Models, Specifications, and Application

Table 67. Shinogi Polyvalent Streptococcus Pneumococcal Vaccines Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 68. Shinogi Company Profile and Main Business

Table 69. Shinogi Recent Developments

Table 70. Shenzhen Kangtai Biological Products Company Information, Head Office, Market Area, and Industry Position

Table 71. Shenzhen Kangtai Biological Products Polyvalent Streptococcus Pneumococcal Vaccines Models, Specifications, and Application

Table 72. Shenzhen Kangtai Biological Products Polyvalent Streptococcus Pneumococcal Vaccines Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 73. Shenzhen Kangtai Biological Products Company Profile and Main Business

Table 74. Shenzhen Kangtai Biological Products Recent Developments

Table 75. SK Bioscience Company Information, Head Office, Market Area, and Industry Position

Table 76. SK Bioscience Polyvalent Streptococcus Pneumococcal Vaccines Models, Specifications, and Application

Table 77. SK Bioscience Polyvalent Streptococcus Pneumococcal Vaccines Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 78. SK Bioscience Company Profile and Main Business

Table 79. SK Bioscience Recent Developments

Table 80. Walvax Biotechnology Company Information, Head Office, Market Area, and Industry Position

Table 81. Walvax Biotechnology Polyvalent Streptococcus Pneumococcal Vaccines Models, Specifications, and Application

Table 82. Walvax Biotechnology Polyvalent Streptococcus Pneumococcal Vaccines Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 83. Walvax Biotechnology Company Profile and Main Business

Table 84. Walvax Biotechnology Recent Developments

Table 85. Eli Lilly Company Information, Head Office, Market Area, and Industry Position

Table 86. Eli Lilly Polyvalent Streptococcus Pneumococcal Vaccines Models, Specifications, and Application

Table 87. Eli Lilly Polyvalent Streptococcus Pneumococcal Vaccines Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 88. Eli Lilly Company Profile and Main Business

Table 89. Eli Lilly Recent Developments

Table 90. Abera Company Information, Head Office, Market Area, and Industry Position

Table 91. Abera Polyvalent Streptococcus Pneumococcal Vaccines Models, Specifications, and Application

Table 92. Abera Polyvalent Streptococcus Pneumococcal Vaccines Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 93. Abera Company Profile and Main Business

Table 94. Abera Recent Developments

Table 95. Sanofi Company Information, Head Office, Market Area, and Industry Position

Table 96. Sanofi Polyvalent Streptococcus Pneumococcal Vaccines Models, Specifications, and Application

Table 97. Sanofi Polyvalent Streptococcus Pneumococcal Vaccines Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 98. Sanofi Company Profile and Main Business

Table 99. Sanofi Recent Developments

Table 100. Genentech Company Information, Head Office, Market Area, and Industry Position

Table 101. Genentech Polyvalent Streptococcus Pneumococcal Vaccines Models, Specifications, and Application

Table 102. Genentech Polyvalent Streptococcus Pneumococcal Vaccines Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 103. Genentech Company Profile and Main Business

Table 104. Genentech Recent Developments

List of Figures

Figure 1. Polyvalent Streptococcus Pneumococcal Vaccines Picture

Figure 2. Global Polyvalent Streptococcus Pneumococcal Vaccines Consumption Value, (US$ million) & (2020-2031)

Figure 3. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Quantity, (K Units) & (2020-2031)

Figure 4. Global Polyvalent Streptococcus Pneumococcal Vaccines Average Selling Price (ASP), (2020-2031) & (US$/Unit)

Figure 5. China Polyvalent Streptococcus Pneumococcal Vaccines Consumption Value, (US$ million) & (2020-2031)

Figure 6. China Polyvalent Streptococcus Pneumococcal Vaccines Sales Quantity (K Units) & (2020-2031)

Figure 7. China Polyvalent Streptococcus Pneumococcal Vaccines Average Selling Price (ASP), (US$/Unit) & (2020-2031)

Figure 8. By Consumption Value, China Polyvalent Streptococcus Pneumococcal Vaccines Market Share of Global, 2020-2031

Figure 9. By Sales Quantity, China Polyvalent Streptococcus Pneumococcal Vaccines Market Share of Global, 2020-2031

Figure 10. Global Polyvalent Streptococcus Pneumococcal Vaccines Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2024

Figure 11. China Polyvalent Streptococcus Pneumococcal Vaccines Key Participants, Market Share, 2024

Figure 12. Global Polyvalent Streptococcus Pneumococcal Vaccines Capacity, Production and Capacity Utilization, 2020-2031

Figure 13. Global Polyvalent Streptococcus Pneumococcal Vaccines Capacity Market Share by Region, 2024 VS 2031

Figure 14. Global Polyvalent Streptococcus Pneumococcal Vaccines Production Market Share & Forecast by Region, 2020-2031

Figure 15. Polyvalent Streptococcus Pneumococcal Vaccines Industry Chain

Figure 16. Polyvalent Streptococcus Pneumococcal Vaccines Procurement Model

Figure 17. Polyvalent Streptococcus Pneumococcal Vaccines Sales Model

Figure 18. Polyvalent Streptococcus Pneumococcal Vaccines Sales Channels, Direct Sales, and Distribution

Figure 19. 9-Valent

Figure 20. 13-Valent

Figure 21. 23-Valent

Figure 22. Others

Figure 23. by Type, Global Polyvalent Streptococcus Pneumococcal Vaccines Consumption Value, 2020-2031, US$ Million

Figure 24. by Type, Global Polyvalent Streptococcus Pneumococcal Vaccines Consumption Value Market Share, 2020-2031

Figure 25. by Type, Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Quantity, 2020-2031, (K Units)

Figure 26. by Type, Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Quantity Market Share, 2020-2031

Figure 27. by Type, Global Polyvalent Streptococcus Pneumococcal Vaccines Average Selling Price (ASP), 2020-2031, (US$/Unit)

Figure 28. Hospital

Figure 29. Community Clinics

Figure 30. Public Health Agencies

Figure 31. Others

Figure 32. by Application, Global Polyvalent Streptococcus Pneumococcal Vaccines Consumption Value, 2020-2031, US$ Million

Figure 33. by Application, Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share, 2020-2031

Figure 34. by Application, Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Quantity, 2020-2031, (K Units)

Figure 35. by Application, Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Quantity Market Share, 2020-2031

Figure 36. by Application, Global Polyvalent Streptococcus Pneumococcal Vaccines Price, 2020-2031, (US$/Unit)

Figure 37. By Region, Global Polyvalent Streptococcus Pneumococcal Vaccines Consumption Value Market Share, 2020-2031

Figure 38. By Region, Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Quantity Market Share, 2020-2031

Figure 39. North America Polyvalent Streptococcus Pneumococcal Vaccines Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 40. By Country, North America Polyvalent Streptococcus Pneumococcal Vaccines Consumption Value Market Share, 2024

Figure 41. Europe Polyvalent Streptococcus Pneumococcal Vaccines Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 42. By Country, Europe Polyvalent Streptococcus Pneumococcal Vaccines Consumption Value Market Share, 2024

Figure 43. Asia Pacific Polyvalent Streptococcus Pneumococcal Vaccines Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 44. By Country/Region, Asia Pacific Polyvalent Streptococcus Pneumococcal Vaccines Consumption Value Market Share, 2024

Figure 45. South America Polyvalent Streptococcus Pneumococcal Vaccines Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 46. By Country, South America Polyvalent Streptococcus Pneumococcal Vaccines Consumption Value Market Share, 2024

Figure 47. Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 48. United States Polyvalent Streptococcus Pneumococcal Vaccines Sales Quantity, 2020-2031, (K Units)

Figure 49. by Type, United States Polyvalent Streptococcus Pneumococcal Vaccines Sales Quantity Market Share, 2024 VS 2031

Figure 50. by Application, United States Polyvalent Streptococcus Pneumococcal Vaccines Sales Quantity Market Share, 2024 VS 2031

Figure 51. Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales Quantity, 2020-2031, (K Units)

Figure 52. by Type, Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales Quantity Market Share, 2024 VS 2031

Figure 53. by Application, Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales Quantity Market Share, 2024 VS 2031

Figure 54. China Polyvalent Streptococcus Pneumococcal Vaccines Sales Quantity, 2020-2031, (K Units)

Figure 55. by Type, China Polyvalent Streptococcus Pneumococcal Vaccines Sales Quantity Market Share, 2024 VS 2031

Figure 56. by Application, China Polyvalent Streptococcus Pneumococcal Vaccines Sales Quantity Market Share, 2024 VS 2031

Figure 57. Japan Polyvalent Streptococcus Pneumococcal Vaccines Sales Quantity, 2020-2031, (K Units)

Figure 58. by Type, Japan Polyvalent Streptococcus Pneumococcal Vaccines Sales Quantity Market Share, 2024 VS 2031

Figure 59. by Application, Japan Polyvalent Streptococcus Pneumococcal Vaccines Sales Quantity Market Share, 2024 VS 2031

Figure 60. South Korea Polyvalent Streptococcus Pneumococcal Vaccines Sales Quantity, 2020-2031, (K Units)

Figure 61. by Type, South Korea Polyvalent Streptococcus Pneumococcal Vaccines Sales Quantity Market Share, 2024 VS 2031

Figure 62. by Application, South Korea Polyvalent Streptococcus Pneumococcal Vaccines Sales Quantity Market Share, 2024 VS 2031

Figure 63. Southeast Asia Polyvalent Streptococcus Pneumococcal Vaccines Sales Quantity, 2020-2031, (K Units)

Figure 64. by Type, Southeast Asia Polyvalent Streptococcus Pneumococcal Vaccines Sales Quantity Market Share, 2024 VS 2031

Figure 65. by Application, Southeast Asia Polyvalent Streptococcus Pneumococcal Vaccines Sales Quantity Market Share, 2024 VS 2031

Figure 66. India Polyvalent Streptococcus Pneumococcal Vaccines Sales Quantity, 2020-2031, (K Units)

Figure 67. by Type, India Polyvalent Streptococcus Pneumococcal Vaccines Sales Quantity Market Share, 2024 VS 2031

Figure 68. by Application, India Polyvalent Streptococcus Pneumococcal Vaccines Sales Quantity Market Share, 2024 VS 2031

Figure 69. Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Sales Quantity, 2020-2031, (K Units)

Figure 70. by Type, Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Sales Quantity Market Share, 2024 VS 2031

Figure 71. by Application, Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Sales Quantity Market Share, 2024 VS 2031

Figure 72. Research Methodology

Figure 73. Breakdown of Primary Interviews

Figure 74. Bottom-up Approaches

Figure 75. Top-down Approaches